Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Filings indexed 1,617 across all filing types
Latest filing 2020-08-11 Share Issue/Capital Cha…
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
公告本公司董事會決議註銷庫藏股及訂定減資基準日
Share Issue/Capital Change Classification · 100% confidence The document is a company announcement regarding a board resolution to cancel treasury shares and set a capital reduction base date. It includes specific details about the reduction amount, shares canceled, and dates. The content is a formal regulatory announcement about capital structure changes, specifically a reduction in capital through cancellation of treasury shares. It is not a full financial report, audit, or earnings release, but an update on capital changes. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is short and focused on this capital change event, confirming the classification.
2020-08-11 Chinese
109年07月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, managers, and their family members, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider share ownership and transactions, which aligns with reporting requirements for personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not a report publication announcement or a certification but a detailed insider shareholding disclosure. Therefore, the appropriate classification is Director's Dealing (DIRS).
2020-08-10 Chinese
109年07月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by company insiders, including directors, supervisors, and executives. It lists the number of shares held at appointment and currently held, as well as pledged shares and their proportions. The document does not contain financial statements, earnings data, or management discussion. It is a disclosure of insider shareholdings and pledges, which corresponds to reporting of personal share transactions or holdings by company directors and executives. Therefore, the document fits the category of Director's Dealing (DIRS). The document length is 2418 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report.
2020-08-10 Chinese
109年7月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 景岳, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements, no management discussion, no audit information, no voting results, no legal proceedings, and no mention of any report publication. The content is a regulatory disclosure of financial guarantees and loans, typical of a regulatory filing or compliance announcement. The document length is very short (601 characters), and it does not contain or reference a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2020-08-10 Chinese
109年7月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 景岳, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or audit information. The length is only 765 characters, which is very short and more consistent with a brief financial summary or factsheet rather than a full report. There is no indication that this is an announcement of a report publication or a regulatory filing. Given the concise financial data and summary nature, this fits best as a Fund Information / Factsheet (FS) type document, which typically provides brief key financial facts and market info.
2020-08-10 Chinese
108年度股利金額(股東會決議)
Notice of Dividend Amount Classification · 95% confidence The document contains detailed information about dividend distribution, including cash dividends per share, dates of board resolutions and shareholder meetings, and explanations of dividend policies. It focuses on the announcement of dividend amounts and related shareholder distribution details. The document length is short (1896 characters) and it primarily provides dividend distribution data rather than a full financial report or earnings release. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2020-07-23 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.